Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
258.8 SEK | -0.23% | +2.37% | -3.07% |
Mar. 14 | Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024. | CI |
Feb. 13 | Sobi to Expand in South Korea via Rare Disease JV with Handok | MT |
Sales 2024 * | 24.13B 2.2B | Sales 2025 * | 26.84B 2.45B | Capitalization | 88.13B 8.03B |
---|---|---|---|---|---|
Net income 2024 * | 3.53B 321M | Net income 2025 * | 4.87B 444M | EV / Sales 2024 * | 4.26 x |
Net Debt 2024 * | 14.73B 1.34B | Net Debt 2025 * | 9.52B 868M | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
25.2
x | P/E ratio 2025 * |
18.7
x | Employees | 1,772 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.87% |
Latest transcript on Swedish Orphan Biovitrum AB
1 day | -1.16% | ||
1 week | +2.06% | ||
Current month | -3.44% | ||
1 month | -2.27% | ||
3 months | -11.70% | ||
6 months | +23.56% | ||
Current year | -3.37% |
Managers | Title | Age | Since |
---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 59 | 17-05-21 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 57 | 18-07-19 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sven Ullman
BRD | Director/Board Member | 68 | 20-12-31 |
Annette Clancy
CHM | Chairman | 70 | 14-05-07 |
Staffan Schüberg
BRD | Director/Board Member | 55 | 19-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 233 M€ | +5.85% | ||
0.90% | 5 M€ | +5.20% | ||
0.69% | 148 M€ | +4.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 258.8 | -0.23% | 63 600 |
24-04-18 | 259.4 | +1.41% | 323,531 |
24-04-17 | 255.8 | -1.01% | 225,294 |
24-04-16 | 258.4 | +1.65% | 259,785 |
24-04-15 | 254.2 | +0.55% | 274,439 |
Delayed Quote Nasdaq Stockholm, April 19, 2024 at 03:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.37% | 8.07B | |
-5.99% | 84.46B | |
+3.95% | 40.85B | |
-26.37% | 27.69B | |
+50.89% | 24.28B | |
-6.59% | 17.09B | |
-32.37% | 13.67B | |
-10.45% | 11.79B | |
-15.88% | 11.86B | |
+0.53% | 7.51B |
- Stock Market
- Equities
- SOBI Stock